Skip to content

haMSter: a Novel Smartphone Communication Tool for People With MS

haMSter: a Novel Smartphone Communication Tool for People With MS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04555863
Enrollment
50
Registered
2020-09-21
Start date
2020-04-01
Completion date
2021-06-01
Last updated
2021-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M-health, Multiple Sclerosis

Keywords

m-health, multiple sclerosis, patient reported outcomes

Brief summary

haMSter is a smartphone app that tracks validated patient reported outcome measures (PROMs) in people multiple sclerosis (MS). In this study, 50 patients with MS will receive this app for 6 months and be asked to fill out the PRO questionnaires on their Smartphone. Endpoints include the adherence to this app and satisfaction with this Intervention.

Interventions

DEVICEhaMSter smartphone app

the app tracks patient reported outcomes

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Any MS according to MacDonald criteria * informed consent

Exclusion criteria

\- language barriers

Design outcomes

Primary

MeasureTime frameDescription
adherence to deviceover the course of this study (over 6 months)Percentage (Number) of participants having completed all necessary questionnaires per study period. Max: 6 completions.

Secondary

MeasureTime frameDescription
Overall satisfaction with this application in telemedicineafter study completion (after 6 months)TMPQ (Telemedicine Perception Questionnaire). Min: 0 points. Max: 80 Points. Higher scores indicate a better outcome
General satisfaction with specific Features of the haMSter appafter study completion (after 6 months)Empirical questionnaires. We will Report frequencies of answers given. There is no Overall score in a larger sense.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026